In some ways, healthcare is ready to take on addressing social determinants of health, but there still needs to be a cultural shift in mindset in a lot of ways, said Rachel Gold, PhD, MPH, investigator at the Kaiser Permanente Northwest Center for Health Research and lead research scientist at OCHIN.
In some ways, healthcare is ready to take on addressing social determinants of health, but there still needs to be a cultural shift in mindset in a lot of ways, said Rachel Gold, PhD, MPH, investigator at the Kaiser Permanente Northwest Center for Health Research and lead research scientist at OCHIN.
Transcription:
In general, how ready is healthcare to get involved with addressing social determinants of health?
I’d say the health care system is, in some ways, ready to take this on, and, in some ways, not. Again, my focus is on community health centers. I think pediatrics, primary care, and family medicine, in particular, are specialties in those areas of care that understand and know that social determinants affect health. That’s obvious to folks that are dealing with patients, especially, in primary care, family medicine, and pediatrics. So, I think they’re ready in that they understand the stuff affects our patients’ health.
I think the challenge is, you get folks who are trained to be clinical care providers being asked now to also be, in some ways, social workers, and, in some ways, make referrals to community agencies. Then, there’s these staffing issues involved with, do you have to have a social worker on staff? Can you afford to have a social worker on staff? Are they going to be there all the time? How do you get patients? How do you help support healthcare systems? Take that next step beyond sort of knowing that a patient’s needs are affecting their health, or maybe trying to address them in a non-systematic way to facilitate them helping with community referrals in a systematic way.
I think it involves a certain amount of a cultural shift for healthcare staff to think about, “oh now we’re addressing that too? Now we have to take that on?” I do think folks in the medical system are ready in some levels, and not in others, because of that cultural shift that’s going to be involved with making that referral. That’s really an issue around acculturating healthcare providers to think this is also something they need to take on.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Safety and Efficacy Updates for Asthma and Urticaria Therapies
April 5th 2025The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and favorable hematological safety profile of remibrutinib, were highlighted at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Safety and Efficacy Updates for Asthma and Urticaria Therapies
April 5th 2025The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and favorable hematological safety profile of remibrutinib, were highlighted at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
2 Commerce Drive
Cranbury, NJ 08512